Skip to content

Depression Management at the Workplace

Influencing Employer Purchasing Behavior

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01013220
Acronym
DMW
Enrollment
293
Registered
2009-11-13
Start date
2009-01-31
Completion date
2014-09-30
Last updated
2014-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

depression, depression care management, financing, absenteeism, presenteeism, employer decisions to purchase health care benefits

Brief summary

Randomized trials demonstrate that depression management products can improve clinical and organizational outcomes sufficiently for selected employers to realize a return on investment. Rather than usual care marketing which uses voltage-enhanced promises to sell voltage-diminished products, the investigators designed an evidence-based (EB) intervention to encourage employers to purchase a depression management product that offers the type, intensity and duration of care shown to provide clinical and organizational value. In an RCT designed to examine employer benefit purchasing behavior of depression products in 360 employer members of over 20 regional business coalitions, the research team proposes: (a) to compare the impact of evidence-based (EB) to usual care (UC) presentations on employer benefit purchasing behavior, and (b) to identify mediators and organizational moderators of intervention impact on employer benefit purchasing behavior. This study addresses what policy analysts argue is one of the most pivotal problems in the translation of evidence-based care to 'real world' settings: whether purchasers can be influenced to buy health care products on the basis of value rather than cost. In the likely event that EB \> UC, the study will provide encouragement to use an evidence-based approach to market new health care products to private payers on the basis of the product's clinical and organizational value. UC may achieve comparable outcomes to EB if the limiting factors in benefit purchasing are organizational, purchasing group and vendor constraints that no intervention can meaningfully modify. Support for this scenario would encourage the targeted marketing of new products to coalition members with empirically identified organizational, purchasing group and vendor characteristics, using usual care strategies.

Interventions

OTHERDepression Product Detailing

1. two hour academic detailing of depression management products to employees with responsibility for purchasing health care benefits 2. technical assistance in purchasing high quality depression management products

OTHERDepression HEDIS detailing

1. academic detailing to employees responsible for purchasing health care benefits on how to use HEDIS indicators for depression to assure their depressed employees receive high quality care for the condition 2. technical assistance

Sponsors

Colorado Business Group on Health
CollaboratorOTHER
University of South Florida
CollaboratorOTHER
Florida State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Coalitions who belong to the National Business Coalition on Health are eligible if: * they have 30+ employer purchasers/affiliates as members * they act as more than purchasing agents * (3)they did not participate in the research team's preliminary studies on this topic. * Employers of participating coalitions are eligible if: * they are a public or private organization providing health care benefits to 100+ domestic employees * they have not purchased a depression management product in the past two years.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
employer purchase of depression management producttwo years after intervention

Secondary

MeasureTime frame
fidelity of depression management model purchased to evidence-based modelstwo years after intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026